Merck : MRK

All Merck Articles

1079 Articles

Paul Ausick | Nov 18, 2014 at 9:10 AM EST

Companies Spending the Most on R&D

For the third consecutive year, the company spending the most on research and development (R&D) was Germany's Volkswagen.

Paul Ausick | Nov 14, 2014 at 4:48 PM EST

The 4 DJIA Stocks That Weighed Down Friday’s Market

thinkstockNovember 14, 2014: Markets opened mixed on Friday following a jump in U.S. consumer sentiment coupled with better-than-expected reports on…

Lee Jackson | Nov 13, 2014 at 9:15 AM EST

4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic

A new research report from the analysts at UBS focuses on four companies that stand to benefit from rising demand…

Paul Ausick | Oct 30, 2014 at 4:01 PM EDT

The 4 DJIA Stocks That Dominated the Market

thinkstockOctober 30, 2014: Markets opened mixed again on Thursday with the DJIA opening higher on the strength of a big…

Paul Ausick | Oct 27, 2014 at 4:01 PM EDT

The 4 DJIA Stocks That Guided Markets to a Mixed Close

thinkstockOctober 27, 2014: Markets opened lower on Monday as traders hit back at Brazilian voters who re-elected Dilma Rousseff as…

Chris Lange | Oct 27, 2014 at 8:40 AM EDT

Merck Earnings Look Very Mixed in Major Restructuring

Merck reported better-than-expected third-quarter earnings Monday morning.

Jon C. Ogg | Oct 24, 2014 at 8:05 AM EDT

Pfizer Stock Buyback Plan Just Too Large to Ignore — It Is on Viagra

Pfizer's new buyback is simply too large and too significant to ignore, and it might jokingly be called "on Viagra."

Paul Ausick | Oct 13, 2014 at 4:01 PM EDT

The 4 DJIA Stocks Sank the Market

thinkstockOctober 13, 2014: Markets opened lower on Monday, a holiday for all but the equity markets. There was no economic…

Jon C. Ogg | Oct 10, 2014 at 9:30 AM EDT

Short Sellers Getting Smart in Defensive High-Yield Dividend Stocks

Short sellers have decided to get out of some of the go-to defensive stocks with high-dividend yields in late September.

Paul Ausick | Oct 8, 2014 at 4:01 PM EDT

The 4 Stocks That Dominated the Market

thinkstockOctober 8, 2014: Markets opened mixed on Wednesday with virtually no economic data and little other news until the release…

Paul Ausick | Oct 3, 2014 at 4:01 PM EDT

The 4 Stocks That Boosted the Market

thinkstockOctober 3, 2014: Markets opened higher on Friday following the report on September non-farm payrolls which showed better-than-expected improvement. The…

Jon C. Ogg | Sep 29, 2014 at 4:05 PM EDT

The Best- and Worst-Performing DJIA Stocks in 2014

The bull market may be five and a half years old, but stocks have been fighting each week to hit…

Jon C. Ogg | Sep 25, 2014 at 9:50 AM EDT

Short Sellers Run for Cover in Defensive High-Yield Dividend Stocks

24/7 Wall St. takes look at what is happening in the short interest of the go-to high-dividend defensive stocks.

Jon C. Ogg | Sep 24, 2014 at 6:45 AM EDT

The Best Performing DJIA Stocks of 2014

The bull market may be five and a half years old, but stocks have been fighting each week to hit…

Lee Jackson | Sep 18, 2014 at 8:15 AM EDT

Credit Suisse Gold Standard Yield Stocks May Be the Safest to Own Now

Here are the four "Gold Standard" stocks from Credit Suisse that offer a combination of a higher yield and more…

1 … 45 46 47 48 49 … 72

Merck : MRK

All Merck Articles

Companies Spending the Most on R&D

The 4 DJIA Stocks That Weighed Down Friday’s Market

4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic

The 4 DJIA Stocks That Dominated the Market

The 4 DJIA Stocks That Guided Markets to a Mixed Close

Merck Earnings Look Very Mixed in Major Restructuring

Pfizer Stock Buyback Plan Just Too Large to Ignore — It Is on Viagra

The 4 DJIA Stocks Sank the Market

Short Sellers Getting Smart in Defensive High-Yield Dividend Stocks

The 4 Stocks That Dominated the Market

The 4 Stocks That Boosted the Market

The Best- and Worst-Performing DJIA Stocks in 2014

Short Sellers Run for Cover in Defensive High-Yield Dividend Stocks

The Best Performing DJIA Stocks of 2014

Credit Suisse Gold Standard Yield Stocks May Be the Safest to Own Now

Forget VOO: Fidelity’s Tech ETF Is Up 29% While the Broad Market Lags

The Dividend Growth Path That Hauls in a Bigger Paycheck Than Your HR Rep

Why SpaceX Is About to Spend Billions on Something It Can’t Launch

The Dividend Growth Path That Hauls in a Bigger Paycheck Than Your HR Rep

The 401(k) Bracket Smoothing Math: Why a 66 Year Old Couple With $1.5 Million Should Convert Exactly $90,000 a Year

3 Robotics Stocks in the M&A Spotlight in 2026

Forget VOO: Fidelity’s Tech ETF Is Up 29% While the Broad Market Lags

Merck : MRK

All Merck Articles

Companies Spending the Most on R&D

The 4 DJIA Stocks That Weighed Down Friday’s Market

4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic

The 4 DJIA Stocks That Dominated the Market

The 4 DJIA Stocks That Guided Markets to a Mixed Close

Merck Earnings Look Very Mixed in Major Restructuring

Pfizer Stock Buyback Plan Just Too Large to Ignore — It Is on Viagra

The 4 DJIA Stocks Sank the Market

Short Sellers Getting Smart in Defensive High-Yield Dividend Stocks

The 4 Stocks That Dominated the Market

The 4 Stocks That Boosted the Market

The Best- and Worst-Performing DJIA Stocks in 2014

Short Sellers Run for Cover in Defensive High-Yield Dividend Stocks

The Best Performing DJIA Stocks of 2014

Credit Suisse Gold Standard Yield Stocks May Be the Safest to Own Now

Forget VOO: Fidelity’s Tech ETF Is Up 29% While the Broad Market Lags

The Dividend Growth Path That Hauls in a Bigger Paycheck Than Your HR Rep

Why SpaceX Is About to Spend Billions on Something It Can’t Launch

Featured Reads

The Dividend Growth Path That Hauls in a Bigger Paycheck Than Your HR Rep

The 401(k) Bracket Smoothing Math: Why a 66 Year Old Couple With $1.5 Million Should Convert Exactly $90,000 a Year